dobutamine has been researched along with Amyloidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertl, G; Herrmann, S; Hu, K; Liu, D; Lorenz, K; Nordbeck, P; Salinger, T | 1 |
| Ewald, G; Mindel, G; Saab, G; Vijayan, A | 1 |
2 other study(ies) available for dobutamine and Amyloidosis
| Article | Year |
|---|---|
Cardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography.
Topics: Adrenergic beta-1 Receptor Agonists; Aged, 80 and over; Amyloidosis; Aortic Valve Stenosis; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotonic Agents; Diagnosis, Differential; Dobutamine; Echocardiography, Stress; Echocardiography, Transesophageal; Hemodynamics; Humans; Male; Predictive Value of Tests; Reproducibility of Results; Severity of Illness Index; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2017 |
Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Amyloidosis; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Male; Middle Aged; Milrinone; Norepinephrine; Peritoneal Dialysis; Phenylephrine; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2002 |